BMRA
Price
$2.33
Change
-$0.01 (-0.43%)
Updated
Feb 4, 01:26 PM (EDT)
Capitalization
7.19M
Intraday BUY SELL Signals
NVCR
Price
$11.56
Change
-$0.28 (-2.36%)
Updated
Feb 4, 03:07 PM (EDT)
Capitalization
1.33B
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMRA vs NVCR

Header iconBMRA vs NVCR Comparison
Open Charts BMRA vs NVCRBanner chart's image
Biomerica
Price$2.33
Change-$0.01 (-0.43%)
Volume$948
Capitalization7.19M
NovoCure
Price$11.56
Change-$0.28 (-2.36%)
Volume$600
Capitalization1.33B
BMRA vs NVCR Comparison Chart in %
View a ticker or compare two or three
VS
BMRA vs. NVCR commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRA is a Hold and NVCR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (BMRA: $2.34 vs. NVCR: $11.84)
Brand notoriety: BMRA and NVCR are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BMRA: 6% vs. NVCR: 81%
Market capitalization -- BMRA: $7.19M vs. NVCR: $1.33B
BMRA [@Medical/Nursing Services] is valued at $7.19M. NVCR’s [@Medical/Nursing Services] market capitalization is $1.33B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $189.57B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.77B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRA’s FA Score shows that 1 FA rating(s) are green whileNVCR’s FA Score has 1 green FA rating(s).

  • BMRA’s FA Score: 1 green, 4 red.
  • NVCR’s FA Score: 1 green, 4 red.
According to our system of comparison, NVCR is a better buy in the long-term than BMRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRA’s TA Score shows that 3 TA indicator(s) are bullish while NVCR’s TA Score has 4 bullish TA indicator(s).

  • BMRA’s TA Score: 3 bullish, 6 bearish.
  • NVCR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NVCR is a better buy in the short-term than BMRA.

Price Growth

BMRA (@Medical/Nursing Services) experienced а -4.10% price change this week, while NVCR (@Medical/Nursing Services) price change was -9.27% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -0.31%, and the average quarterly price growth was +14.02%.

Reported Earning Dates

NVCR is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Medical/Nursing Services (-2.76% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCR($1.33B) has a higher market cap than BMRA($7.19M). BMRA YTD gains are higher at: -7.143 vs. NVCR (-8.430). BMRA has higher annual earnings (EBITDA): -4.86M vs. NVCR (-113.5M). NVCR has more cash in the bank: 1.03B vs. BMRA (2.54M). BMRA has less debt than NVCR: BMRA (284K) vs NVCR (798M). NVCR has higher revenues than BMRA: NVCR (642M) vs BMRA (4.46M).
BMRANVCRBMRA / NVCR
Capitalization7.19M1.33B1%
EBITDA-4.86M-113.5M4%
Gain YTD-7.143-8.43085%
P/E RatioN/AN/A-
Revenue4.46M642M1%
Total Cash2.54M1.03B0%
Total Debt284K798M0%
FUNDAMENTALS RATINGS
BMRA vs NVCR: Fundamental Ratings
BMRA
NVCR
OUTLOOK RATING
1..100
7164
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
7963
P/E GROWTH RATING
1..100
1009
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRA's Valuation (31) in the Medical Specialties industry is significantly better than the same rating for NVCR (100). This means that BMRA’s stock grew significantly faster than NVCR’s over the last 12 months.

BMRA's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVCR (100). This means that BMRA’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's SMR Rating (97) in the Medical Specialties industry is in the same range as BMRA (98). This means that NVCR’s stock grew similarly to BMRA’s over the last 12 months.

NVCR's Price Growth Rating (63) in the Medical Specialties industry is in the same range as BMRA (79). This means that NVCR’s stock grew similarly to BMRA’s over the last 12 months.

NVCR's P/E Growth Rating (9) in the Medical Specialties industry is significantly better than the same rating for BMRA (100). This means that NVCR’s stock grew significantly faster than BMRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRANVCR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 28 days ago
79%
Bullish Trend 14 days ago
74%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
BMRA
Daily Signal:
Gain/Loss:
NVCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NEIMX39.770.12
+0.30%
Neiman Large Cap Value No-Load
CLREX54.88-0.42
-0.76%
Columbia Balanced Inst2
FTPIX90.85-0.80
-0.87%
Invesco Technology R5
NBFCX33.34-0.48
-1.42%
Neuberger Focus Trust
STITX7.44-0.14
-1.85%
Virtus SGA International Growth I

BMRA and

Correlation & Price change

A.I.dvisor tells us that BMRA and LFWD have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMRA and LFWD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRA
1D Price
Change %
BMRA100%
-2.90%
LFWD - BMRA
29%
Poorly correlated
-1.81%
SENS - BMRA
29%
Poorly correlated
-1.66%
NVCR - BMRA
28%
Poorly correlated
-2.87%
EKSO - BMRA
26%
Poorly correlated
-3.20%
INFU - BMRA
26%
Poorly correlated
+0.61%
More

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with AVNS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then AVNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
-2.87%
AVNS - NVCR
41%
Loosely correlated
-0.37%
QTRX - NVCR
39%
Loosely correlated
-0.77%
BLFS - NVCR
39%
Loosely correlated
+2.28%
KIDS - NVCR
38%
Loosely correlated
-1.85%
ALGN - NVCR
38%
Loosely correlated
-4.02%
More